NASDAQ:CYPH Cypherpunk Technologies (CYPH) Stock Price, News & Analysis $0.64 -0.01 (-1.23%) As of 11:27 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About Cypherpunk Technologies Stock (NASDAQ:CYPH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CYPH alerts:Sign Up Key Stats Today's Range$0.62▼$0.6550-Day Range$0.52▼$0.8152-Week Range$0.25▼$3.70Volume188,940 shsAverage Volume3.26 million shsMarket Capitalization$68.13 millionP/E Ratio1.14Dividend YieldN/APrice Target$0.90Consensus RatingModerate Buy Company Overview Cypherpunk Technologies Inc., previously known as Leap Therapeutics, Inc., is a company developing novel therapies for patients with cancer and implementing a digital asset treasury strategy focused on Zcash. The company’s research platform centers on modulating the tumor microenvironment to enhance anti-tumor immune responses. Cypherpunk’s proprietary pipeline includes DKN-01, a monoclonal antibody designed to neutralize Dickkopf-1 (DKK1), a protein implicated in tumor growth and immune evasion. DKN-01 is being evaluated both as a monotherapy and in combination with checkpoint inhibitors such as pembrolizumab across multiple solid tumor indications, including gastroesophageal, pancreatic and other advanced malignancies. In addition to DKN-01, Cypherpunk is advancing preclinical programs that target novel pathways involved in cancer cell signaling and immune regulation, with the aim of identifying complementary assets for future clinical development. Founded in 2016 and headquartered in Irvine, California, Leap Therapeutics completed its initial public offering in 2019 and now trades on the NASDAQ under the ticker CYPH. The company conducts clinical trials in the United States and collaborates with academic and industry partners to accelerate its development programs. Michael Stoll, M.D., serves as President and Chief Executive Officer, overseeing a team of experienced professionals in oncology drug discovery and development. AI Generated. May Contain Errors. Read More Cypherpunk Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks67th Percentile Overall ScoreCYPH MarketRank™: Cypherpunk Technologies scored higher than 67% of companies evaluated by MarketBeat, and ranked 278th out of 913 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingModerate Buy Consensus RatingCypherpunk Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, no buy ratings, no hold ratings, and 1 sell rating.Upside PotentialCypherpunk Technologies has a consensus price target of $0.90, representing about 38.9% upside from its current price of $0.65.Amount of Analyst CoverageCypherpunk Technologies has only been the subject of 2 research reports in the past 90 days.Read more about Cypherpunk Technologies' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cypherpunk Technologies is 1.16, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.58.Price to Earnings Ratio vs. SectorThe P/E ratio of Cypherpunk Technologies is 1.16, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 269.63.Price to Book Value per Share RatioCypherpunk Technologies has a P/B Ratio of 0.35. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted7.10% of the float of Cypherpunk Technologies has been sold short.Short Interest Ratio / Days to CoverCypherpunk Technologies has a short interest ratio ("days to cover") of 6.13.Change versus previous monthShort interest in Cypherpunk Technologies has recently decreased by 9.86%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCypherpunk Technologies does not currently pay a dividend.Dividend GrowthCypherpunk Technologies does not have a long track record of dividend growth. News and Social Media2.2 / 5News Sentiment0.55 News SentimentCypherpunk Technologies has a news sentiment score of 0.55. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Cypherpunk Technologies this week, compared to 2 articles on an average week. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cypherpunk Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders3.50% of the stock of Cypherpunk Technologies is held by insiders.Percentage Held by Institutions30.46% of the stock of Cypherpunk Technologies is held by institutions.Read more about Cypherpunk Technologies' insider trading history. Receive CYPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cypherpunk Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CYPH Stock News HeadlinesCypherpunk Technologies Inc.: Cypherpunk Technologies Reports Second Quarter 2026 Financial ResultsAugust 12 at 8:37 AM | finanznachrichten.deCypherpunk Technologies Reports Second Quarter 2026 Financial ResultsAugust 12 at 7:05 AM | prnewswire.comTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security. The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move.August 14 at 1:00 AM | Porter & Company (Ad)Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer ResearchAugust 12 at 7:00 AM | prnewswire.comCypherpunk Technologies Faces Nasdaq Listing Compliance WarningJuly 21, 2026 | tipranks.comCypherpunk Technologies Reports First Quarter 2026 Financial ResultsMay 14, 2026 | prnewswire.comCypherpunk Increases its Zcash Stake, Launches New Website and Investor DashboardApril 15, 2026 | prnewswire.comCypherpunk Technologies Announces Planned Board Leadership TransitionsApril 12, 2026 | theglobeandmail.comSee More Headlines CYPH Stock Analysis - Frequently Asked Questions How have CYPH shares performed this year? Cypherpunk Technologies' stock was trading at $1.16 on January 1st, 2026. Since then, CYPH stock has decreased by 44.1% and is now trading at $0.6480. How were Cypherpunk Technologies' earnings last quarter? Cypherpunk Technologies (NASDAQ:CYPH) announced its quarterly earnings data on Wednesday, August, 12th. The company reported $0.18 earnings per share for the quarter. When did Cypherpunk Technologies' stock split? Cypherpunk Technologies's stock reverse split on Wednesday, June 21st 2023.The 1-10 reverse split was announced on Wednesday, June 21st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, June 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of Cypherpunk Technologies? Shares of CYPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/12/2026Today8/14/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (8m+) 1-Year History Aug 25 Nov 25 Feb 26 May 26 Aug 26 CYPH's financial health is in the Yellow zone, according to TradeSmith. CYPH has been in this zone for over 8 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:CYPH Previous SymbolNASDAQ:LPTX CIK1509745 Webwww.leaptx.com Phone(617) 714-0360FaxN/AEmployees40Year Founded2011Price Target and Rating Average Price Target for Cypherpunk Technologies$0.90 High Price Target$0.90 Low Price Target$0.90 Potential Upside/Downside+40.6%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($0.02) Trailing P/E Ratio1.14 Forward P/E RatioN/A P/E GrowthN/ANet Income$4.82 million Net MarginsN/A Pretax MarginN/A Return on Equity-24.59% Return on Assets-22.58% Debt Debt-to-Equity RatioN/A Current Ratio27.28 Quick Ratio27.28 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.83 per share Price / Book0.35Miscellaneous Outstanding Shares106,460,000Free Float102,738,000Market Cap$68.12 million OptionableOptionable Beta0.09 Social Links The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:CYPH) was last updated on 8/14/2026 by MarketBeat.com Staff. From Our PartnersAmerican retirees will miss THIS. Big Banks just moved in.Central banks spent nearly $130 billion on physical gold last year, on top of $145 billion the year before. Q1...Cedar Gold Group | SponsoredThe options guide that actually starts at the beginningMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredAfter KDA, PRE, and OCEAN—this is the one17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...Crypto 101 Media | SponsoredThe Starlink of EnergyA portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cypherpunk Technologies Please log in to your account or sign up in order to add this asset to your watchlist. Share Cypherpunk Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYPH Stock Alerts